Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m(6)A/p21 pathway

Evidence suggests that metformin might be a potential candidate for breast cancer treatment. Yet, its relevant molecular mechanisms remain to be fully investigated. We found that metformin could suppress the N6-methyladenosine (m(6)A) level in breast cancer cells significantly. The latter has an ess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogenesis
Main Authors: Cheng, Lin, Zhang, Xu, Huang, Yu-Zhou, Zhu, Yu-Lan, Xu, Ling-Yun, Li, Zhi, Dai, Xin-Yuan, Shi, Liang, Zhou, Xu-Jie, Wei, Ji-Fu, Ding, Qiang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7801402/
https://ncbi.nlm.nih.gov/pubmed/33431790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-020-00290-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados